Google
Trusted Resources: News & Meetings
Latest announcements and gatherings
COVID-19 Vaccine FAQ — Boston University School of Medicine Amyloidosis Center
Is the COVID-19 vaccine safe?
How effective is it? The United States Food and Drug Administration (FDA) has granted emergency approval for the COVID-19 vaccine. This essentially means that the FDA granted approval based on less information than is normally required, as the typical process takes years to evaluate a new vaccine. The vaccine is said to be the best hope for ending the pandemic, but given how new it is, the public has had a lot of questions about its safety and efficacy.
The vaccines require 2 separate injections given 3 or 4 weeks apart. Neither vaccine uses live COVID-19 viral particles, and therefore cannot give you COVID-19. The COVID-19 vaccines are considered safe. Some people have experienced some mild side-effects from the vaccine including headache, muscle or joint pain, fatigue, and fever.
myBinderRelated Content
-
Institut für Pathologie – Christian-Albrechts-Universität zu KielDas Amyloid Register Kiel widmet sich de...
-
What to Expect on Your hATTR Amyloidosis JourneyFamily History Given the hereditary (ru...
-
International Society of Amyloidosis (ISA)International Society of Amyloidosis (IS...
-
NORD Launches Financial Assistance Program for Rare Disease Community Members Impacted by COVID-19At this time of crisis and with the heal...
-
Heart Failure Diet: Sodium and Heart FailureHeart Failure Diet Resources and answer...
-
Nikrad Shahnavaz, MDNikrad Shahnavaz is an Associate Profess...
-
The Princess Alexandra Hospital Amyloidosis CentreThe Princess Alexandra Hospital (PAH) Am...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Community Key Collaborator
Support for this landing page is provided by an independent education grant from
Translation of this platform made possible through an independent education grant from
Powered by
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
